HIV

February 18, 2021

VUMC investigator expands HIV research into South Africa

A Vanderbilt University Medical Center investigator is hoping to improve access to HIV testing in South Africa, where more than 7 million people are known to have the virus, by training traditional healers to perform the tests.

By Jake Lowary
HIV cell
February 8, 2021

Key factors in HIV-1 replication

HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication.

By Anivarya Kumar
December 10, 2020

HIV patients stay away after Nigerian clinic introduces fees

Six years ago, in Nigeria, funding cutbacks for HIV treatment and the consequent introduction of patient fees were associated with sharp declines in new HIV clinic enrollments and patient adherence to antiretroviral therapy (ART).

By Paul Govern
October 16, 2020

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.

By Bill Snyder
June 9, 2020

VIGH awarded $3 million for building research capacity in Nigeria and Mozambique

Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique.

By Kristin Centers
March 21, 2019

Pediatric HIV researcher Carlucci discusses work in Mozambique

When James Carlucci, MD, MPH, instructor of Pediatric Infectious Diseases, is in Nashville he treats children at Monroe Carell Jr. Children’s Hospital at Vanderbilt. When he’s on one of the several trips he takes each year to Mozambique, he’s trying to understand when and why HIV-exposed infants fall out of care — and how to change it.

By Holly Fletcher
September 20, 2018

New HIV research training program launched

With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs.
By Paul Govern
June 8, 2018

A “public” target for HIV

Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus.
By Bill Snyder
November 9, 2017

HIV outreach and return to care

When chronic disease patients let their care lapse and fail to show for clinic appointments, it may behoove clinics to reach out and encourage a return to care.
By Paul Govern
October 12, 2017

VIGH receives federal grants to fight kidney disease

Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.
By Bill Snyder
October 5, 2017

Major international study testing therapy to prevent spread of HIV

Nine more volunteers are needed to complete a study at Vanderbilt University Medical Center (VUMC) that could lead to a way to prevent the spread of HIV (human immunodeficiency virus).
By Bill Snyder
September 7, 2017

Combination therapy PrEP offers effective way to prevent HIV infection

Rates of new HIV infections in the United States are declining — except among men who have sex with men. Rates are particularly high among African-American and Hispanic men and especially in the South.
By Bill Snyder
September 1, 2017

Restricting HIV-1 infection

Vanderbilt researchers are discovering ways that host proteins block HIV-1 infection, which could suggest new avenues for treatment.
By Leigh MacMillan
1 2 3 4